Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER_GOV 1

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Genitourinary 1

Conditions

Colorectal Neoplasms 3Sarcoma 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Stage IIIb and IV Non Small Cell Lung Cancer 1Recurrence 1Prostatic Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Microsatellite Instability 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × High-Throughput Nucleotide Sequencing × Clear all
NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

NCT05158621 2022-10-18

A Screening Study Targeting Tumor-specific Antigens

Gritstone bio, Inc.

Completed
22 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03794128 2020-09-11

A Study of Personalized Neoantigen Cancer Vaccines

Gritstone bio, Inc.

Completed
93 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡